Pathophysiology and treatment of neurodegenerative disorders
Featured publications
-
Ikzf1 as a novel regulator of microglial homeostasis in inflammation and neurodegeneration
Ballasch I; García-García E; Vila C; Pérez-González A; Sancho-Balsells A;(...)Gasull X; Alberch J; Rodríguez MJ; Canals JM; Giralt A .Reference:Brain Behavior And Immunity 2023.
-
Increased phospho-AKT in blood cells from LRRK2 G2019S mutation carriers
Garrido A; Pérez-Sisqués L; Simonet C; Campoy-Campos G; Solana-Balaguer J;(...)Tolosa E; Martí MJ; Ezquerra M; Malagelada C; Fernández-Santiago R .Reference:Annals Of Neurology 2022.
-
GPC3-Unc5 receptor complex structure and role in cell migration
Akkermans O; Delloye-Bourgeois C; Peregrina C; Carrasquero-Ordaz M; Kokolaki M;(...)Owens RJ; Robinson CV; Castellani V; Del Toro D; Seiradake E .Reference:Cell 2022.
-
Altered m6A RNA methylation contributes to hippocampal memory deficits in Huntington's disease mice
Pupak A; Singh A; Sancho-Balsells A; Alcalá-Vida R; Espina M;Giralt A; Martí E; Ørom UAV; Ginés S; Brito V .Reference:Cellular And Molecular Life Sciences 2022.
-
Translating cell therapies for neurodegenerative diseases: Huntington's disease as a model disorder
Rosser AE; Busse ME; Gray WP; Badin RA; Perrier AL;(...)Mills LJ; Drew C; Goldman SA; Canals JM; Thompson LM .Reference:Brain 2022.
-
Huntington’s disease brain-derived small RNAs recapitulate associated neuropathology in mice
Creus-Muncunill J; Guisado-Corcoll A; Venturi V; Pantano L; Escaramís G;(...)Masana M; Llorens F; Diaz-Lucena D; Pérez-Navarro E; Martí E.Reference:Acta Neuropathologica 2021.
-
Neuron type-specific increase in lamin B1 contributes to nuclear dysfunction in Huntington’s disease
Alcalá-Vida R; Garcia-Forn M; Castany-Pladevall C; Creus-Muncunill J; Ito Y;(...)Samarajiwa S; Peiró S; Di Croce L; Narita M; Pérez-Navarro E.Reference:Embo Molecular Medicine 2021.
-
M2 cortex-dorsolateral striatum stimulation reverses motor symptoms and synaptic deficits in Huntington's disease
Fernández-García S; Conde-Berriozabal S; García-García E; Gort-Paniello C; Bernal-Casas D;(...)Campa L; Artigas F; Rodríguez MJ; Alberch J; Masana M .Reference:Elife 2020.
-
Increased translation as a novel pathogenic mechanism in Huntington's disease
Creus-Muncunill J; Badillos-Rodríguez R; Garcia-Forn M; Masana M; Barriga G;(...)Alberch J; Malagelada C; Delgado-García J; Gruart A; Pérez-Navarro E.Reference:Brain 2019.
-
Cyclin-Dependent Kinase 5 Dysfunction Contributes to Depressive-like Behaviors in Huntington's Disease by Altering the DARPP-32 Phosphorylation Status in the Nucleus Accumbens
Brito V; Giralt A; Masana M; Royes A; Espina M;Sieiro E; Alberch J; Castañé A; Girault J; Ginés S.Reference:Biological Psychiatry 2019.